| 1 |
35012754 | CAR T-cell therapy for B-cell lymphoma. | 2022 Feb |
1 |
| 2 |
35469489 | New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma. | 2022 Apr 26 |
1 |
| 3 |
33385585 | A Real-Time Quantitative PCR Targeting the Viral Vector for the Monitoring of Patients Treated with Axicabtagene Ciloleucel. | 2021 Apr |
1 |
| 4 |
33448873 | Axicabtagene ciloleucel and brexucabtagene autoleucel in relapsed and refractory diffuse large B-cell and mantle cell lymphomas. | 2021 Apr |
1 |
| 5 |
34041526 | CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel. | 2021 Sep 23 |
1 |
| 6 |
32670869 | CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences. | 2020 |
1 |